Molecular Targets of CNS Tumors 2011
DOI: 10.5772/22461
|View full text |Cite
|
Sign up to set email alerts
|

Insulin-Like Growth Factor Binding Protein-2: A Possible Regulator of Invasive Growth in Glioblastoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
31
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(32 citation statements)
references
References 70 publications
0
31
1
Order By: Relevance
“…GPNMB (glycoprotein nonmetastatic melanoma protein B) encodes for a transmembrane protein implicated in a variety of biological process including cell differentiation, inflammation, tissue regeneration, and invasion and metastasis of malignant tumors (Huang et al, 2012). IGFBP2 encodes insulin-like growth factor-binding protein 2 which inhibits insulin-like growth factor and is overexpressed in glioblastomas (Fukushima and Kataoka, 2007); no definite seizure-related mechanism has been described. Insulin-like growth factor regulation is altered in brains after ketogenic diets although IGFBP2 does not appear involved (Cheng et al, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…GPNMB (glycoprotein nonmetastatic melanoma protein B) encodes for a transmembrane protein implicated in a variety of biological process including cell differentiation, inflammation, tissue regeneration, and invasion and metastasis of malignant tumors (Huang et al, 2012). IGFBP2 encodes insulin-like growth factor-binding protein 2 which inhibits insulin-like growth factor and is overexpressed in glioblastomas (Fukushima and Kataoka, 2007); no definite seizure-related mechanism has been described. Insulin-like growth factor regulation is altered in brains after ketogenic diets although IGFBP2 does not appear involved (Cheng et al, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…12,40,48 The overexpression of some IGFBP isoforms has been well documented in gliomas, in particular, glioblastoma (GBM). 15,16,32,43,46 A previous study by our group identified IGFBP-3 as a novel biomarker associated with an adverse GBM prognosis. 46 Additionally, IGFBP-3 has been recognized as a hypoxia-induced gene in a study on a malignant glioma cell line (U251).…”
mentioning
confidence: 99%
“…31 IGFBP is a pleiotropic factor involved in cellular proliferation, motility, and differentiation of microvessel ECs and SMCs. [32][33][34][35][36][37][38] IGFBP2 enhances the cellular invasive capability and upregulates invasionenhancing proteins, such as MMP2. 33,[36][37][38][39] The invasiveness of cells parallels many of the processes in angiogenesis, such as the loss of tumor suppressor genes APC, PTEN, and p53 as well as activating similar signaling pathways and their downstream effectors.…”
mentioning
confidence: 99%